Evaluation of Cortisol Resistance in Young Sedentary and Endurance-Trained Men
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE3
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
- Status
- TERMINATED
- Phase
- NA
Corticosteroids as Additive in Temporomandibular Joint (TMJ) Arthrocentesis
- Status
- UNKNOWN
- Phase
- PHASE4
Ozurdex for Macular Edema Post Membrane Peeling
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial Corticoids For Empyema And Pleural Effusion In Children
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone Metastases
- Status
- COMPLETED
- Phase
- PHASE3
Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Carfilzomib, Pegylated Liposomal Doxorubicin Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Single Oral Dose of Dexamethasone Versus Five Days of Prednisone in Adult Asthma
- Status
- COMPLETED
- Phase
- PHASE4
Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis
- Status
- UNKNOWN
- Phase
- PHASE3
High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose Dexamethasone
- Status
- COMPLETED
- Phase
- PHASE2
RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3